Allurion Technologies is dedicated to helping people transform their health and realize their full potential with products that are safe, effective, affordable, and scalable. The company's flagship product, the Elipse Balloon, is a swallowable, procedureless weight loss device that resides in the stomach, inducing satiety and promoting weight loss.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/11/17 | $27,000,000 | Series C |
Cogepa Investments IDO Investments Romulus Capital  | undisclosed |
